Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Clain

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
The Journal of Clinical Psychiatry|February 7, 2014
A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in major depressive disorderDavid Mischoulon, Lawrence H Price, Linda L Carpenter, et al.
CNS Spectrums|July 14, 2012
Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatmentDavid Mischoulon, Stefania Lamon-Fava, Jacob Selhub, et al.
Hepato-Gastroenterology|June 18, 2002
Interferon-alpha-2b and ribavirin for retreatment of chronic hepatitis CRobert M Dettmer, John F Reinus, David J Clain, et al.
The Journal of Clinical Psychiatry|August 25, 2022
Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Randomized Dose-Finding Clinical TrialDavid Mischoulon, Boadie W Dunlop, Becky Kinkead, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
The Journal of Clinical Psychiatry|February 7, 2014
A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in major depressive disorderDavid Mischoulon, Lawrence H Price, Linda L Carpenter, et al.
CNS Spectrums|July 14, 2012
Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatmentDavid Mischoulon, Stefania Lamon-Fava, Jacob Selhub, et al.
Hepato-Gastroenterology|June 18, 2002
Interferon-alpha-2b and ribavirin for retreatment of chronic hepatitis CRobert M Dettmer, John F Reinus, David J Clain, et al.
The Journal of Clinical Psychiatry|August 25, 2022
Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Randomized Dose-Finding Clinical TrialDavid Mischoulon, Boadie W Dunlop, Becky Kinkead, et al.
Pageof 7